Meribendan is a phosphodiesterase-III inhibitor primarily used for the treatment of chronic heart failure to improve hemodynamic parameters through its chrono-inodilatory effects. To ensure the safety… Read more
Meribendan is a phosphodiesterase-III inhibitor primarily used for the treatment of chronic heart failure to improve hemodynamic parameters through its chrono-inodilatory effects. To ensure the safety and efficacy of this medication, pharmaceutical laboratories rely on high-quality reference standards for rigorous analytical testing and method validation. This category includes the Meribendan active pharmaceutical ingredient, alongside its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for accurate impurity profiling and quantitative analysis during the development and quality control stages of pharmaceutical manufacturing. By utilizing these precise reference materials, researchers and quality assurance teams can reliably identify degradation products and monitor chemical stability, ensuring compliance with strict regulatory standards throughout the drug development lifecycle.